Toni Kim
Pediatric Endocrinology · Sandy Springs, GANPI 1518003771
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $108,123 of the $160,360 with a category attached, or 67.4%. Ascendis Pharma Endocrinology Inc accounts for 87.6% of it on its own, with 23 other manufacturers making up the rest. Among pediatric endocrinology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 341 payments — averaging $470.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ascendis Pharma Endocrinology Inc$140K
- Neurocrine Biosciences, Inc.$11K
- Pfizer$6K
- Novo Nordisk$550
- Tolmar, Inc.$425
- Insulet Corporation$356
- plus $2K from 18 others
Across 12 payments — averaging $1049.85 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ascendis Pharma Endocrinology Inc$13K
What the payments were for
- Consulting fees$15,1149%
- Speaking & faculty fees$108,12367%
- Travel & lodging$30,11319%
- Food & beverage$6,6154%
- Education$3960%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ascendis Pharma Endocrinology Inc | 208 | $140,492 |
| Neurocrine Biosciences, Inc. | 16 | $10,976 |
| Pfizer | 11 | $5,937 |
| Novo Nordisk | 20 | $550 |
| Tolmar, Inc. | 4 | $425 |
| Insulet Corporation | 18 | $356 |
| AbbVie | 13 | $342 |
| Abbott | 4 | $303 |
| Xeris Pharmaceuticals, Inc. | 10 | $171 |
| AstraZeneca | 5 | $104 |
| Ferring Pharmaceuticals Inc. | 4 | $86 |
| Arbor Pharmaceuticals, Inc. | 4 | $84 |
| Tolmar Pharmaceuticals, Inc. | 4 | $84 |
| Dexcom, Inc. | 4 | $80 |
| Eton Pharmaceuticals, Inc. | 2 | $69 |
| Endo Pharmaceuticals Inc. | 4 | $63 |
| Rhythm Pharmaceuticals, Inc. | 1 | $60 |
| Ultragenyx Pharmaceutical Inc. | 2 | $46 |
| Tandem Diabetes Care, Inc. | 2 | $35 |
| Aegerion Pharmaceuticals, Inc. | 1 | $24 |
| Biomarin Pharmaceutical Inc. | 1 | $23 |
| Amneal Pharmaceuticals LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $16 |
| Medtronic | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SKYTROFA$126,412
- CRENESSITY$9,654
- NGENLA$5,006
- GENOTROPIN$790
- FENSOLVI$400
- FreeStyle Libre Pro$250
- Synthroid$108
How this compares
$160,360 in reported general payments places this provider in the 95th percentile of 30 pediatric endocrinology providers in Georgia.
Other pediatric endocrinology in Sandy Springs
- Quentin VanmeterAtlanta$215K
- Eric FelnerAtlanta$24K
- Jessica HutchinsMacon$21K
- Anil PiyaSavannah$14K
- Juliana Vera OrtizNewnan$13K
- Daniel HsiaAtlanta$6K
- Jacqueline ChanAugusta$3K
- Tarek BisatMacon$3K
- Eric VelazquezMacon$3K
- Joey LowCumming$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.